Neostigmine for non-mild acute pancreatitis: A systematic review and meta-analysis of randomized controlled trials

Background: The therapeutic value of neostigmine as a prokinetic drug in acute pancreatitis (AP), especially in non-mild AP, including moderately severe and severe AP remains controversial. This meta-analysis aimed to investigate the efficacy of neostigmine treatment in patients with non-mild AP. Me...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Kun, Wang, Yabing, Li, Jianing, Bai, Xiaoyin, Yang, Zihan, Han, Xianlin, Wu, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011075/
https://www.ncbi.nlm.nih.gov/pubmed/36925642
http://dx.doi.org/10.3389/fphar.2023.1131974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011075/
https://www.ncbi.nlm.nih.gov/pubmed/36925642
http://dx.doi.org/10.3389/fphar.2023.1131974

Ejemplares similares